Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous diseases caused by monoclonal immunoglobulin and/or free light chains (monoclonal gammopathy of cutaneous significance).

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

Changes in hemostasis and other disorders caused by monoclonal immunoglobulin and/or free light chains.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

Polyclonal hypergammaglobulinemia, infiltration of the salivary glands, lymphadenopathy, and kidney damage - Mikulicz's disease, Sjögren's syndrome, or Castleman's disease? Case report and overview of differential diagnosis and treatment.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

MOF-74(M) (M = Mg(II), Fe(II), Ni(II)) frameworks to enable accelerated redox kinetics for Li-S batteries.

Scientific reports·2025
Same author

Monoclonal gammopathy of clinical significance - a group name for diseases caused by monoclonal immunoglobulin and/ or free light chains. A change in the approach to non-malignant gammopathies.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025
Same author

Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitors.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025
Same journal

68Ga-DOTATOC PET/CT - a case report of synchronous oncological duplicity with high expression of somatostatin receptors.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Differences in the imaging of Erdheim-Chester disease using FDG-PET/CT, NaF-PET/CT examinations, and skeletal scintigraphy. Regression of the disease after treatment with cladribine combined with cyclophosphamide and anakinra.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

From progression to complete remission - a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Second and subsequent lines of systemic therapy in endometrial cancer - a real-life clinical experience.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Chronic low-grade fever or fever with mild lymphadenopathy may indicate Castleman disease if no malignant, autoimmune, or infectious cause of the lymphadenopathy is identified.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Clinical presentations of the most common histiocytic disorders.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
See all related articles

Related Experiment Video

Updated: Feb 23, 2026

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.7K

Biobanking - the First Step to Successful Liquid Biopsy Experiments.

M Almasi, S Sevcikova, M Penka

    Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
    |September 15, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Effective biobanking in the Czech Republic is crucial for research, especially in hematooncology. Collaboration between biobanks ensures sufficient biological material for robust scientific analysis and discovery.

    More Related Videos

    Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
    08:01

    Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

    Published on: November 30, 2022

    5.8K
    Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
    14:54

    Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

    Published on: September 11, 2023

    3.3K

    Related Experiment Videos

    Last Updated: Feb 23, 2026

    A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
    05:26

    A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

    Published on: September 16, 2022

    4.7K
    Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
    08:01

    Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

    Published on: November 30, 2022

    5.8K
    Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
    14:54

    Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

    Published on: September 11, 2023

    3.3K

    Area of Science:

    • Biomedical research
    • Biobanking and sample management
    • Hematooncology

    Background:

    • Biobanking is essential for research, enabling the collection of sufficient biological material for biomarker analysis.
    • Challenges in biobanking include obtaining adequate tumor cell fractions for diagnosing conditions like monoclonal gammopathies.
    • Adapting biobanking practices is necessary for detecting minimal residual disease using bone marrow and liquid biopsies.

    Purpose of the Study:

    • To highlight the significance of biological material archiving in the Czech Republic.
    • To present practical applications of biobanked materials in hematooncology research.

    Main Methods:

    • Review of existing biobanking practices and their role in research.
    • Analysis of case studies demonstrating the utility of archived samples in hematooncology.

    Main Results:

    • Archived biological materials are vital for addressing research questions requiring statistically significant sample sizes.
    • Cooperation among biobanks, sharing standards and sample availability information, facilitates rapid acquisition of critical research materials.

    Conclusions:

    • The availability of a critical mass of specimens is key to solving research challenges.
    • Inter-biobank collaboration is essential for efficient archiving and sample accessibility.
    • Standardized practices and information sharing enhance the value of biobanks for scientific advancement.